SCHEMBL4902609

SCHEMBL4902609

CCN(c1csc(-c2ccc(C(F)(F)F)cc2)n1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 7/20 0.43
MAPT P10636 3/20 0.41
POLB P06746 3/20 0.40
KDM4E B2RXH2 2/20 0.39
LMNA P02545 2/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
MEN1 O00255 1/20 0.39
HSP90AA1 P07900 1/20 0.39
CRHBP P24387 1/20 0.39
KMT2A Q03164 1/20 0.39
CRHR2 Q13324 1/20 0.39
HDAC8 Q9BY41 2/20 0.38
HDAC3 O15379 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4908323 0.92 NR1I2 (0.40) TP53MAPTKDM4ESMN1; SMN2GAA
SCHEMBL4908938 0.90 SCN10A (0.44) TP53MAPTKDM4EALDH1A1TSHR
SCHEMBL4902584 0.90 MAPT (0.43) TP53MAPTKDM4ELMNASMN1; SMN2
SCHEMBL4895709 0.90 TP53 (0.43) TP53MAPTPOLBKDM4ELMNA
SCHEMBL4902470 0.90 TP53 (0.43) TP53MAPTPOLBLMNASMN1; SMN2
SCHEMBL4904147 0.88 ALDH1A1 (0.45) TP53MAPTLMNASMN1; SMN2GAA
SCHEMBL4905533 0.85 KDM4E (0.42) TP53MAPTKDM4EGAAL3MBTL1
SCHEMBL4902676 0.84 ALDH1A1 (0.44) TP53MAPTKDM4ELMNASMN1; SMN2
SCHEMBL4906847 0.83 ALDH1A1 (0.38) MAPTKDM4ELMNASMN1; SMN2GAA
SCHEMBL4894519 0.83 HDAC8 (0.52) MAPTPOLBLMNAGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD TP53 3260/4885MAPT 1858/4885POLB 1488/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TP53 3421/4885MAPT 1786/4885POLB 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.